On May 8, Omrix Biopharmaceuticals
- Revenue grew by 25.4% to $14.1 million, largely because of strong performances in the biosurgery and immunotherapy segments.
- Net profit increased a paltry 4.6% due to compressed margins.
- Omrix anticipates that the Food and Drug Administration will approve Evicel and thrombin this quarter for patients undergoing vascular surgery.
- For the fiscal year, the company anticipates product sales will be $50 million to $55 million.
(Figures in thousands, except per-share data.)
Income Statement Highlights
|
Q1 2007 |
Q1 2006 |
Change |
|
|---|---|---|---|
|
Sales |
$14,169.0 |
$11,302.0 |
25.4% |
|
Net Profit |
$3,382.0 |
$3,234.0 |
4.6% |
|
EPS |
$0.20 |
$0.29 |
(31.0%) |
|
Diluted Shares |
17,305.9 |
11,167.4 |
55.0% |
Get back to basics with a look at the income statement.
Margin Checkup
|
Q1 2007 |
Q1 2006 |
Change* |
|
|---|---|---|---|
|
Gross Margin |
38.2% |
45.6% |
(7.5) |
|
Operating Margin |
15.4% |
26.1% |
(10.8) |
|
Net Margin |
23.9% |
28.6% |
(4.7) |
Margins are the earnings engine.
Balance Sheet Highlights
|
Assets |
Q1 2007 |
Q1 2006 |
Change |
|---|---|---|---|
|
Cash + ST Invest. |
$83,743.0 |
$2,662.0 |
3,045.9% |
|
Accounts Rec. |
$13,570.0 |
$8,116.0 |
67.2% |
|
Inventory |
$18,637.0 |
$11,243.0 |
65.8% |
|
Liabilities |
Q1 2007 |
Q1 2006 |
Change |
|---|---|---|---|
|
Accounts Payable* |
$14,071.0 |
$14,229.0 |
(1.1%) |
|
Long-Term Debt |
$201.0 |
$3,190.0 |
(93.7%) |
The balance sheet reflects the company's health.
Cash Flow Highlights
The company didn't provide a statement of cash flows.
Free cash flow is a Fool's best friend.
Related Foolishness:
Omrix is a Rule Breakers recommendation. A free trial to Rule Breakers gives you a chance to chat with other investors and our analysts about the technologies that will change our lives and help our portfolios.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
